Consumer Counsel Gets $115M From EpiPen Settlement

By J. Edward Moreno · November 17, 2021, 6:19 PM EST

A Kansas federal judge granted final approval to the $345 million settlement between Pfizer and the consumer classes that accused it of scheming to inflate the price of its emergency allergy...

To view the full article, register now.

Documents

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017